PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Thursday reported a loss of $111 million in its fourth quarter.
On a per-share basis, the Palo Alto, California-based company said it had a loss of 90 cents. Losses, adjusted for one-time gains and costs, came to 62 cents per share.
The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.
The provider of oncology testing services posted revenue of $201.8 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $199.9 million.
For the year, the company reported a loss of $436.4 million, or $3.56 per share. Revenue was reported as $739 million.
Guardant Health expects full-year revenue in the range of $850 million to $860 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH
/Nvidia%20logo%20and%20sign%20on%20headquarters%20by%20Michael%20Vi%20via%20Shutterstock.jpg)
/Micron%20Technology%20Inc_%20logo%20on%20building-by%20vzphotos%20vis%20iStock.jpg)